The present invention relates to novel compounds of formula (I) wherein W, n,X and W' are defined in thedescription; invention compounds are modulators of metabotropic glutamatereceptors - subtype 5 ("mGluR5") which are useful for thetreatment of central nervous system disorders as well as other disordersmodulated by mGluR5 receptors.